Cytokine production in patients with cirrhosis and TLR4 polymorphisms

World Journal of Gastroenterology

Volumn 20, Issue 46, 2014, Pages 17516-17524

  Nieto, Juan Camilo ^a   Sánchez, Elisabet ^a,b,c   Román, Eva ^a,b,c,d   Vidal, Silvia ^a   Oliva, Laia ^a   Guarner Argente, Carlos ^b   Poca, Maria ^b   Torras, Xavier ^b,c   Juárez, Cándido ^a   Guarner, Carlos ^a,b,c   Soriano, German ^a,b,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Escola Universitària d Infermeria EUI Sant Pau   (Spain)

Author keywords

Genetic factors; Hepatic encephalopathy; Infections; Inflammatory response

Indexed keywords

GENOMIC DNA; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; TEICHOIC ACID; TLR4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HEPATIC ENCEPHALOPATHY; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LIVER FAILURE; MALE; CASE CONTROL STUDY; CELL CULTURE; DISEASE COURSE; DRUG EFFECTS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PHENOTYPE;

ADULT; AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINES; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEPATIC ENCEPHALOPATHY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84918504114     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i46.17516     Document Type: Article

References (40)

1. Bellot P, Francés R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int 2013; 33: 31-39 [PMID: 23121656 DOI: 10.1111/liv.12021]
2. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005; 17: 27-31 [PMID: 15647636]
3. Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut 2009; 58: 704-720 [PMID: 19359436 DOI: 10.1136/gut.2008.156307]
4. Francés R, Zapater P, González-Navajas JM, Muñoz C, Caño R, Moreu R, Pascual S, Bellot P, Pérez-Mateo M, Such J. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology 2008; 47: 978-985 [PMID: 18306221 DOI: 10.1002/hep.22083]
5. Albillos A, de la Hera A, González M, Moya JL, Calleja JL, Monserrat J, Ruiz-del-Arbol L, Alvarez-Mon M. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37: 208-217 [PMID: 12500206 DOI: 10.1053/jhep.2003.50038]
6. Tazi KA, Quioc JJ, Abdel-Razek W, Tellier Z, Guichard C, Ogier-Denis E, Lebrec D, Moreau R. Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study. Hepatol Res 2009; 39: 706-715 [PMID: 19473436 DOI: 10.1111/j.1872-034X.2009.00498.x]
7. Cervoni JP, Thévenot T, Weil D, Muel E, Barbot O, Sheppard F, Monnet E, Di Martino V. C-reactive protein predicts short-term mortality in patients with cirrhosis. J Hepatol 2012; 56: 1299-1304 [PMID: 22314431 DOI: 10.1016/j.jhep.2011.12.030]
8. Zapater P, Francés R, González-Navajas JM, de la Hoz MA, Moreu R, Pascual S, Monfort D, Montoliu S, Vila C, Escudero A, Torras X, Cirera I, Llanos L, Guarner-Argente C, Palazón JM, Carnicer F, Bellot P, Guarner C, Planas R, Solá R, Serra MA, Muñoz C, Pérez-Mateo M, Such J. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 2008; 48: 1924-1931 [PMID: 19003911 DOI: 10.1002/hep.22564]
9. Córdoba J, Mínguez B. Hepatic encephalopathy. Semin Liver Dis 2008; 28: 70-80 [PMID: 18293278 DOI: 10.1055/s-2008-1040322]
10. Butterworth RF. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 2011; 53: 1372-1376 [PMID: 21480337 DOI: 10.1002/hep.24228]
11. Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2010; 51: 1062-1069 [PMID: 19890967 DOI: 10.1002/hep.23367]
12. Knapp S, von Aulock S, Leendertse M, Haslinger I, Draing C, Golenbock DT, van der Poll T. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J Immunol 2008; 180: 3478-3484 [PMID: 18292574]
13. Good DW, George T, Watts BA. Toll-like receptor 2 is required for LPS-induced Toll-like receptor 4 signaling and inhibition of ion transport in renal thick ascending limb. J Biol Chem 2012; 287: 20208-20220 [PMID: 22523073 DOI: 10.1074/jbc.M111.336255]
14. Schröder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005; 5: 156-164 [PMID: 15766650 DOI: 10.1016/S1473-3099(05)01308-3]
15. Misch EA, Hawn TR. Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond) 2008; 114: 347-360 [PMID: 18230059 DOI: 10.1042/CS20070214]
16. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-191 [PMID: 10835634 DOI: 10.1038/76048]
17. Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, Hemming VG, Blanco JC, Segal DM, Vogel SN. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 2006; 177: 322-332 [PMID: 16785528]
18. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, Netea MG. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 2008; 14: 346-352 [PMID: 18231573 DOI: 10.2119/2007-00135.Ferwerda]
19. Guarner-Argente C, Sánchez E, Vidal S, Román E, Concepción M, Poca M, Sánchez D, Juárez C, Soriano G, Guarner C. Toll-like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patients. Aliment Pharmacol Ther 2010; 31: 1192-1199 [PMID: 20222908 DOI: 10.1111/j.1365-2036.2010.04291.x]
20. Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, Layden TJ, Wright TL, White T, Cheung RC. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 2007; 46: 297-306 [PMID: 17461418 DOI: 10.1002/hep.21695]
21. Francés R, Rodríguez E, Muñoz C, Zapater P, De la ML, Ndongo M, Pérez-Mateo M, Such J. Intracellular cytokine expression in peritoneal monocyte/macrophages obtained from patients with cirrhosis and presence of bacterial DNA. Eur J Gastroenterol Hepatol 2005; 17: 45-51 [PMID: 15647640]
22. Testro AG, Gow PJ, Angus PW, Wongseelashote S, Skinner N, Markovska V, Visvanathan K. Effects of antibiotics on expression and function of Toll-like receptors 2 and 4 on mononuclear cells in patients with advanced cirrhosis. J Hepatol 2010; 52: 199-205 [PMID: 20006396 DOI: 10.1016/j.jhep.2009.11.006]
23. Lin CY, Tsai IF, Ho YP, Huang CT, Lin YC, Lin CJ, Tseng SC, Lin WP, Chen WT, Sheen IS. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 2007; 46: 816-826 [PMID: 17328986 DOI: 10.1016/j.jhep.2006.12.018]
24. Devière J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E. Excessive in vitro bacterial lipopoly-saccharide-induced production of monokines in cirrhosis. Hepatology 1990; 11: 628-634 [PMID: 2184115]
25. Ramírez MJ, Ibáñez A, Navasa M, Casals E, Morales-Ruiz M, Jiménez W, Arroyo V, Rodés J. High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites. J Hepatol 2004; 40: 424-430 [PMID: 15123356 DOI: 10.1016/j.jhep.2003.11.017]
26. Montes AH, Asensi V, Alvarez V, Valle E, Ocaña MG, Meana A, Carton JA, Paz J, Fierer J, Celada A. The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis. Clin Exp Immunol 2006; 143: 404-413 [PMID: 16487238 DOI: 10.1111/j.1365-2249.2005.03002. x]
27. Mueller M, Stamme C, Draing C, Hartung T, Seydel U, Schromm AB. Cell activation of human macrophages by lipoteichoic acid is strongly attenuated by lipopolysaccharide-binding protein. J Biol Chem 2006; 281: 31448-31456 [PMID: 16928689 DOI: 10.1074/jbc.M605966200]
28. Prohinar P, Rallabhandi P, Weiss JP, Gioannini TL. Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4. J Immunol 2010; 184: 4362-4367 [PMID: 20212095 DOI: 10.4049/jimmunol.0903142]
29. Ferwerda B, McCall MB, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, Izagirre N, Syafruddin D, Kibiki G, Cristea T, Hijmans A, Hamann L, Israel S, ElGhazali G, Troye-Blomberg M, Kumpf O, Maiga B, Dolo A, Doumbo O, Hermsen CC, Stalenhoef AF, van Crevel R, Brunner HG, Oh DY, Schumann RR, de la Rúa C, Sauerwein R, Kullberg BJ, van der Ven AJ, van der Meer JW, Netea MG. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA 2007; 104: 16645-16650 [PMID: 17925445 DOI: 10.1073/pnas.0704828104]
30. Erridge C, Stewart J, Poxton IR. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Tolllike receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 2003; 197: 1787-1791 [PMID: 12796470 DOI: 10.1084/jem.20022078]
31. von Aulock S, Schröder NW, Gueinzius K, Traub S, Hoffmann S, Graf K, Dimmeler S, Hartung T, Schumann RR, Hermann C. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis 2003; 188: 938-943 [PMID: 12964127 DOI: 10.1086/378095]
32. van der Graaf C, Kullberg BJ, Joosten L, Verver-Jansen T, Jacobs L, Van der Meer JW, Netea MG. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine 2005; 30: 264-268 [PMID: 15927851 DOI: 10.1016/j.cyto.2005.02.001]
33. Zapater P, Caño R, Llanos L, Ruiz-Alcaraz AJ, Pascual S, Barquero C, Moreu R, Bellot P, Horga JF, Muñoz C, Pérez J, García-Peñarrubia P, Pérez-Mateo M, Such J, Francés R. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis. Gastroenterology 2009; 137: 1669-79.e1 [PMID: 19660462 DOI: 10.1053/j.gastro.2009.07.058]
34. Appenrodt B, Grünhage F, Gentemann MG, Thyssen L, Sauerbruch T, Lammert F. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology 2010; 51: 1327-1333 [PMID: 20087966 DOI: 10.1002/hep.23440]
35. Romero-Gómez M, Jover M, Del Campo JA, Royo JL, Hoyas E, Galán JJ, Montoliu C, Baccaro E, Guevara M, Córdoba J, Soriano G, Navarro JM, Martínez-Sierra C, Grande L, Galindo A, Mira E, Mañes S, Ruiz A. Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study. Ann Intern Med 2010; 153: 281-288 [PMID: 20820037 DOI: 10.7326/0003-4819-153-5-201009070-00002]
36. Minmin S, Xiaoqian X, Hao C, Baiyong S, Xiaxing D, Junjie X, Xi Z, Jianquan Z, Songyao J. Single nucleotide polymorphisms of Toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma. PLoS One 2011; 6: e19466 [PMID: 21559380 DOI: 10.1371/journal.pone.0019466]
37. Navasa M, Follo A, Filella X, Jiménez W, Francitorra A, Planas R, Rimola A, Arroyo V, Rodés J. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998; 27: 1227-1232 [PMID: 9581675 DOI: 10.1002/hep.510270507]
38. Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, Hamilton JA, Bengmark S, Williams R, Visvanathan K. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 2003; 37: 1154-1164 [PMID: 12717397 DOI: 10.1053/jhep.2003.50180]
39. - monocytes is weakly modulated as a consequence of persistent infection with the hepatitis C virus. Mol Immunol 2011; 48: 1505-1511 [PMID: 21531464 DOI: 10.1016/j.molimm.2011.04.008]
40. von Baehr V, Döcke WD, Plauth M, Liebenthal C, Küpferling S, Lochs H, Baumgarten R, Volk HD. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 2000; 47: 281-287 [PMID: 10896923]